Andlauer Healthcare Group Inc.
TSX:AND.TO
40.51 (CAD) • At close October 22, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) CAD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|
| Revenue
| 647.952 | 648.423 | 440.115 | 314.34 | 289.988 | 277.01 | 251.03 | 223.593 |
| Cost of Revenue
| 500.471 | 489.576 | 329.361 | 234.788 | 221.903 | 214.461 | 196.643 | 172.463 |
| Gross Profit
| 147.481 | 158.847 | 110.754 | 79.552 | 68.085 | 62.549 | 54.387 | 51.13 |
| Gross Profit Ratio
| 0.228 | 0.245 | 0.252 | 0.253 | 0.235 | 0.226 | 0.217 | 0.229 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 51.428 | 48.502 | 37.051 | 28.613 | 23.092 | 21.683 | 20.394 | 20.693 |
| Other Expenses
| -0.409 | -0.328 | 0.368 | -0.049 | -0.145 | 0.019 | 0.439 | 0.224 |
| Operating Expenses
| 51.428 | 48.502 | 37.051 | 28.613 | 23.092 | 21.683 | 20.394 | 20.693 |
| Operating Income
| 96.053 | 110.345 | 73.703 | 50.939 | 44.993 | 40.866 | 33.993 | 30.437 |
| Operating Income Ratio
| 0.148 | 0.17 | 0.167 | 0.162 | 0.155 | 0.148 | 0.135 | 0.136 |
| Total Other Income Expenses Net
| -5.446 | -6.587 | 34.737 | -4.359 | -2.644 | 0.019 | 0.439 | 0.224 |
| Income Before Tax
| 90.607 | 103.758 | 108.44 | 46.58 | 42.349 | 38.716 | 31.701 | 27.916 |
| Income Before Tax Ratio
| 0.14 | 0.16 | 0.246 | 0.148 | 0.146 | 0.14 | 0.126 | 0.125 |
| Income Tax Expense
| 24.467 | 27.483 | 18.486 | 8.866 | 12.004 | 10.531 | 8.517 | 7.439 |
| Net Income
| 66.14 | 76.275 | 89.954 | 37.714 | 29.773 | 26.723 | 21.678 | 19.149 |
| Net Income Ratio
| 0.102 | 0.118 | 0.204 | 0.12 | 0.103 | 0.096 | 0.086 | 0.086 |
| EPS
| 1.58 | 1.82 | 2.3 | 1 | 0.79 | 0.74 | 0.6 | 0.53 |
| EPS Diluted
| 1.55 | 1.79 | 2.25 | 0.98 | 0.79 | 0.74 | 0.6 | 0.53 |
| EBITDA
| 164.202 | 175.068 | 119.454 | 79.197 | 71.558 | 65.255 | 58.465 | 52.911 |
| EBITDA Ratio
| 0.253 | 0.27 | 0.271 | 0.252 | 0.247 | 0.236 | 0.233 | 0.237 |